There are multiple barriers to rare disease diagnosis, including access to testing technologies, availability of knowledgeable health care providers, and lack of uniformity of the phenotype for a given genotype or disease-causing agent.
Watch Now
Workcast
Connective tissue-specific stem and progenitor cells (also known asa mesenchymal stormal/stem cells or MSCs) have been the subject of clinical testing for various conditions, but the outcomes of advanced clinical trials have fallen short of expectations raised by encouraging pre-clinical animal data in a wide array of disease models.
Watch Now
In this webinar, Dr. Wen introduces LIDE Biotech and their range of available services which include personalized oncology. For example, LIDE utilizes next generation sequencing (NGS) or polymerase chain reaction (PCR) testing in cases where driver genes are clearly identified and functional diagnostics in instances where driver genes are unclear. In addition, they offer drug research and development services, from preclinical testing through clinical trials.
Watch Now
on24
Regenerative medicine has become a key focus worldwide and the number of stem cell therapy trials are rapidly increasing every year. Yet, large-scale and GMP-compliant stem cell manufacturing is still a major hurdle for clinical applications across the globe. In this webinar, we will show you how to implement GMP-compliant and scalable manufacturing of different adherent cell types, such as pluripotent stem cells and their derivatives, in the CliniMACS Prodigy® Adherent Cell Culture System.
Watch Now